We are a group of professionals, expert in areas of Legal services, Financial services, HR services, IT services and Management consulting
Despite economic uncertainties and industry shake-ups, America’s entrepreneurial engine is still running full throttle. According to the U.S. Census Bureau, a staggering 5.5 million new business applications were filed last year—a record high. And this year is off to a strong start with another 1.5 million applications already logged in the first quarter alone.
In a striking policy move, former President Donald Trump has reignited his “most-favored-nation” (MFN) drug pricing strategy—this time with a new executive order aimed squarely at reducing prescription costs for Americans. The order mandates that U.S. drug prices align with the lowest prices charged in other developed nations, a shift that Trump claims could slash costs by 30% to 80% “almost immediately.” While the proposal sounds like a win for American patients, the reality is far more complex—especially for those navigating the intersections of business, policy, and innovation.
